Ledger.Open graph →
SEC Form D · Amendment · filed December 16, 2021

FlightPath Biosciences, Inc

Offering
$5.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Mark P. De Souza · Berkeley, CAExec · DirectorMatthew C. Tindall · Berkeley, CAExec · DirectorCurtis L. Scribner · Berkeley, CAExecKevin Diestel · Chicago, ILExecJett Mccandless · Chicago, ILExec · DirectorJoseph Floyd · Chicago, ILExec · DirectorKatherine G. Saxton · Westlake Village, CAExec · DirectorChristopher G. Tune · Westlake Village, CAExecSteve G. De Forest · Westlake Village, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗